Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc (“GSK” or the “Company”)(NYSE: GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. […]

Pomerantz LLP announces that a class action lawsuit has been filed against SoundHound AI, Inc. (“SoundHound” or the “Company”) (NASDAQ: SOUN) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-02915, is on behalf of a class consisting of all persons and

Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. (“Sana” or the “Company”) (NASDAQ: SANA) and certain officers. The class action, filed in the United States District Court for the Western District of Washington, and docketed under 25-cv-00512, is on behalf of a class consisting of all persons and

Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-02563, is on behalf of a class consisting of all persons and entities

Pomerantz LLP announces that a class action lawsuit has been filed against e.l.f. Beauty, Inc. (“Elf” or the “Company”) (NYSE: ELF) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-02316, is on behalf of a class consisting of all persons and

Pomerantz LLP announces that a class action lawsuit has been filed against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-01457, is on behalf of a class consisting of all persons and

Pomerantz LLP announces that a class action lawsuit has been filed against Alarum Technologies Ltd. (“Alarum” or the “Company”) (NASDAQ: ALAR) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-01263, is on behalf of a class consisting of all persons and

Pomerantz LLP announces that a class action lawsuit has been filed against Elastic N.V. (“Elastic” or the “Company”) (NYSE: ESTC) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-00785, is on behalf of a class consisting of all persons and

(OTCQX:VASO),(OTC US:VASO), PLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) — Please note that, in a release issued under the same headline earlier today by Vaso Corporation (OTCQX: VASO), some figures in the written description of the financial results for the three months and the full year were misstated. All figures in the financial tables were

UZ Leuven and VIB-KU Leuven, in collaboration with Seattle-based Presage Biosciences, are announcing the first patient treated in a Non-randomized (phase I – pharmacodynamic only) open label, single center single arm interventional pilot study. By combining intratumoral treatment with systemic anti-PD1 therapy in first line patients with metastatic (stage IV) or inoperable stage III melanoma,